The IL-33 receptor ST2 as a therapeutic target for hemophilic arthropathy

Expert Opinion on Therapeutic Targets 2026

View at publisher
Authors: AJ Lawrence, James S. O’Donnell, Peter L. Turecek, Padraic G. Fallon
DOI: 10.1080/14728222.2026.2619746
Cited by: 0
References: 15

Abstract

1. Hemophilia A and B are X-linked bleeding disorders caused by deficiencies in coagulation factors VIII and IX, respectively, with incidences of approximately 1 in 5,000 and 1 in 30,000 male birth...

Fields of Study & Subjects

Hemophilia Treatment and Research IL-33 ST2 and ILC Pathways Osteoarthritis Treatment and Mechanisms

Publication details

Journal / source
Expert Opinion on Therapeutic Targets
Volume
30
Issue
2
Pages
93–96
Publication date
20 January 2026
Language
EN